Theresa Colligan

Interleukin-6 174G3C Polymorphism Is Associated with Improved Outcome in High-Risk Breast Cancer

B. Weber, A. DeMichele, R. Mick, 2003 .

Drug-metabolizing enzyme polymorphisms predict clinical outcome in a node-positive breast cancer cohort.

T. Rebbeck, B. Weber, P. Gimotty, 2005, Journal of Clinical Oncology.

Interleukin-6 -174G-->C polymorphism is associated with improved outcome in high-risk breast cancer.

B. Weber, A. DeMichele, R. Mick, 2003, Cancer research.